2,3-dibromoquinoxaline

We are 2,3-dibromoquinoxaline CAS:23719-78-0 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

CAS No: 23719-78-0
Product Name: 2,3-dibromoquinoxaline
Other Name:
2,3-dibromoquinoxaline
2,3-dibromo-Quinoxaline
 
Molecular Formula: C8H4Br2N2
Molecular Weight: 287.93900
Exact Mass: 285.87400
PSA: 25.78000
LogP: 3.15480
 
Specification
Appearance: White powder
Assay: ≥98.0%
Water: ≤0.50%
 
Application
Be used as pharmaceutical intermediate.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

2,3-dibromoquinoxaline


Related News: The Breakthrough Designation for the iLet Bionic Pancreas System contemplates configurations with most insulin analogs approved for pumping as well as dasiglucagon, Zealand Pharma’s stable pumpable glucagon analog, which has a unique stability profile in a ready-to-use aqueous solution.174649-09-3 The Breakthrough Designation for the iLet Bionic Pancreas System contemplates configurations with most insulin analogs approved for pumping as well as dasiglucagon, Zealand Pharma’s stable pumpable glucagon analog, which has a unique stability profile in a ready-to-use aqueous solution.147754-12-9 Retrogenix and Resonant Therapeutics, Inc. recently announced they have entered into a non-exclusive strategic partnership to identify the targets of Resonant antibodies directed against the tumor microenvironment.Ethyl 2-(triphenylphosphoranylidene)propionate CAS:5717-37-3 Retrogenix and Resonant Therapeutics, Inc. recently announced they have entered into a non-exclusive strategic partnership to identify the targets of Resonant antibodies directed against the tumor microenvironment.Retrogenix and Resonant Therapeutics, Inc. recently announced they have entered into a non-exclusive strategic partnership to identify the targets of Resonant antibodies directed against the tumor microenvironment.

Related Products
Product Name
(4S,5R)-3-(tert-Butoxycarbonyl)-2,2-dimethyl-4-phenyloxazolidine-5-carboxylic Acid View Details
Pentapeptide-2 View Details
6-chloroguanine View Details
4′-ethynyl-2-fluoro-2′-deoxyadenosine manufacturer Heptamethyltrisiloxane manufacturer Methyl 2-amino-4-((2,5-dichlorophenyl)carbamoyl)benzoate manufacturer 2-Bromo-9,9-diphenyl-9H-fluorene manufacturer cinchomeronic acid manufacturer